期刊文献+

复方更昔洛韦/曲安奈德眼用凝胶的制备及其质量控制 被引量:2

Preparation and Quality Control of Ophthalmic Gel of Compound Ganciclovir/Triamcinolone Acetonide
原文传递
导出
摘要 目的:制备复方更昔洛韦/曲安奈德眼用凝胶,并对其进行质量控制。方法:以卡波姆为基质,制备复方更昔洛韦/曲安奈德眼用凝胶。采用高效液相色谱法测定其中更昔洛韦和曲安奈德的含量,并对其外观形状、黏度、渗透压、pH进行检测。结果:制得的眼用凝胶无色澄清透明,外观均一稳定,黏度为92mpa·S,渗透压为921.66mosmol/kg,pH为6,91;更昔洛韦和曲安奈德的检测质量浓度线性范围分别为30.3~90.9、10.5~73.5μg/ml(r=0.9998),平均回收率分别为99.20%~99.88%、100.29%~100.64%,RSD分别为0.81%~0.90%、0.24%~1.03%(n=3)。结论:该制剂制备方法简单,质量可控。 OBJECTIVE: To prepare Ophthalmic gel of compound ganciclovir/triamcinolone acetonide, and to control the quali- ty of it. METHODS: Carbomer was used as matrix to prepare Ophthalmic gel compound ganciclovir/triamcinolone acetonide. The contents of ganciclovir and triamcinolone acetonide were determined by HPLC. The appearance, viscosity, osmotic pressure and pH value of the gel were all detected. RESULTS: The ophthalmic gel was colorless, clear and transparent, uniform and stable in appearance. The viscosity was 92 mpa-s, and osmotic pressure was 921.66 mosmol/kg (pH=6.91). The linear ranges were 30.3- 90.9 μg/ml for ganciclovir and 10.5-73.5 μg/ml for triamcinolone acetonide (r=0.999 8); average recoveries were 99.20%-99.88% (RSD=0.81%-0.90%, n=3) for ganciclovir and 100.29%-100.64% (RSD=0.24%-1.03%, n=3) for triamcinolone acetonide. CONCLUSIONS: The method is simple and controllable in quality.
出处 《中国药房》 CAS CSCD 2014年第17期1598-1600,共3页 China Pharmacy
关键词 更昔洛韦 曲安奈德 眼用凝胶剂 高效液相色谱法 质量控制 Ganciclovir Triamcinolone acetonide Ophthalmic gel HPLC Quality control
  • 相关文献

参考文献12

二级参考文献76

共引文献139

同被引文献35

  • 1赵东旭,封兴华,吴红,范黎,胡彬,梁志波.聚乳酸-羟基乙酸共聚物作为曲安奈德控释载体的评价[J].中国临床康复,2006,10(37):48-50. 被引量:1
  • 2李俊山,温筱煦,冯端浩.醋酸曲安奈德凝胶的制备和质量控制[J].江西医学院学报,2006,46(5):37-38. 被引量:1
  • 3朱姚亮,刘卫,陈华兵,徐辉碧,杨祥良.醋酸曲安奈德纳米结构脂质载体的制备及其透皮吸收研究[J].中国药科大学学报,2007,38(1):30-34. 被引量:11
  • 4高玉香,闫玉华,金中秋,周雄,商旭敏.生物缓释膜的研制及在青光眼治疗中的应用研究[J].现代生物医学进展,2007,7(8):1184-1186. 被引量:3
  • 5Mailer T, Hen'ling T, LUtge S, et al. Reduction in the Free Radical Status and Clinical Benefit of Repeated Intrathecal Triamcinolone Acetonide Application in Patients With Progressive Multiple Sclerosis [J]. Clin Neuropharmacol, 2014, 37( 1 ) : 22-5.
  • 6冯小路,耿海明,杨波,等.一种含曲安奈德的复方口腔粘贴片及其制备方法:中国专利,CNl03494827A[P].2014-01-08.
  • 7白玲强.一种曲安奈德益康唑乳膏及其制备方法:中国专利,CNl03860566A[P].2014-06-18.
  • 8Hamishehkar H, Nokhodchi A, Ghanbarzadeh S, et al. Triamcinolone Aeetonide Oromucoadhesive Paste for Treatment of Aphthous Stomati- tis[J]. Adv Pharm Bull, 2015, 5(2): 277-82.
  • 9Sabzevari A, Adibkia K, Hashemi H, et al. Improved Anti-Inflam- matory Effects in Rabbit Eye Model Using Biodegradable Poly Beta-A- mino Ester Nanoparticles of Triamcinolone Acetonide[ J]. Invest Oph- thamol Vis Sci, 2013, 54(8) : 5520-6.
  • 10Kadam RS, Tyagi P, Edelhanser HF, et al. Influence of choroidal neovascula-rization and biodegradable polymeric particle size on trans- scleral sustained delivery of triamcinolone acetanide [ J ]. Ira J Pharm, 2012, 434(1-2) : 140-7.

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部